Related references
Note: Only part of the references are listed.Adverse event reports following yellow fever vaccination, 2007-13
Nicole P. Lindsey et al.
JOURNAL OF TRAVEL MEDICINE (2016)
Yellow fever vaccine-associated viscerotropic disease: current perspectives
Roger E. Thomas
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Defining Risk Groups to Yellow Fever Vaccine-Associated Viscerotropic Disease in the Absence of Denominator Data
Stephen J. Seligman et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2014)
Safety profile of the yellow fever vaccine Stamaril®: a 17-year review
Pascale Cottin et al.
EXPERT REVIEW OF VACCINES (2013)
Evaluation of two yellow fever vaccines for routine immunization programs in Argentina
Carlos Ripoll et al.
HUMAN VACCINES (2008)
Yellow fever and Japanese encephalitis vaccines: Indications and complications
AA Marfin et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2005)
History of thymoma and yellow fever vaccination
RB Eidex
LANCET (2004)
Comparative safety and immunogenicity of two yellow fever 17D vaccines (Arilvax and YF-VAX) in a Phase III multicenter, double-blind clinical trial
TP Monath et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2002)
Share Paper
